ISPOR 4TH ASIA‐PACIFIC CONFERENCE DISCLOSURE INFORMATIONThe article lists the financial support disclosed by all contributors as mandated by the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) which includes Shanghai Roche, Novartis, and Pfzer....
ISPOR 8th Asia-Pacific Conference Dates: Saturday, September 8, 2018 - Tuesday, September 11, 2018 Venue: Tokyo,Tokyo,Japan ISPOR is recognized globally as the leading educational and scientific organization for health economics and outcomes research (HEOR) and its use in health care decisions. If...
select article PCN12 Explore-LC: Uniting Existing Real-World DATA Sources to Create a NOVEL ASIA-Pacific Wide Research Platform for NON-SMALL CELL LUNG Cancer Conference abstractOpen archive PCN12 Explore-LC: Uniting Existing Real-World DATA Sources to Create a NOVEL ASIA-Pacific Wide Research Pla...
Discusses studies on the cost effectiveness of treatments for chronic hepatitis B, presented at the 2nd Asia-Pacific Conference of the International Society for Pharmacoeconomics and Outcomes Research. Comparison of peginterferon-α-2a with lamivudine; Cost effectiveness of entecavir; Long term cost ...
Area of residence Asia Pacific 3 16.7 36 14.6 Central & Eastern Europe 3 16.7 4 1.6 Latin America 1 5.6 8 3.2 Middle East 2 11.1 8 3.2 North America 4 22.2 139 56.3 Western Europe 5 27.8 48 19.4 Africa 0 0.0 4 1.6 Professional expertise Clinical/clinical research 4 22.2 NA DHI devel...
ISPOR 4th Asia-Pacific Conference Author IndexNo abstract is available for this article.doi:10.1111/j.1524-4733.2010.00796.xNoneJohn Wiley & Sons, Ltd.Value in Health
Hepatitis B news from the 2nd Asia-Pacific ISPOR conferencedoi:10.2165/00151234-200604990-00010Springer International PublishingPharmacoeconomics & Outcomes News
Review of the ISPOR 5th Asia‑Pacific Conference 2012s for a specific disease area, please contact usorvisit our website (www.costellomedical.com).Cowley Road
Celebrating the 2nd Asia Special Issue: ISPOR Reaching a Six-Year Milestone in the Asia-Pacific Regioneconomic analysiseconomic evaluationeconomic outcomehealth-care decision makershealth economicsObjective: To review the use of evidence in the market approval process, reimbursement, and price control ...
ISPOR 5TH Asia-Pacific Conference Research Abstracts Author Indexdoi:10.1016/S1098-3015(12)04119-8NoneELSEVIERValue in Health